Rare blood-clotting issue dominates COVID news as Denmark scraps AstraZeneca vaccine

Rare blood-clotting issue dominates COVID news as Denmark scraps AstraZeneca vaccine
Ciara Linnane
·9 min read

The growing concerns about a rare blood-clotting disorder that has been reported in people who received the vaccines developed by AstraZeneca PLC and Oxford University and Johnson & Johnson dominated COVID-19 news on Wednesday, with Denmark becoming the first country to fully discontinue use of the AstraZeneca jab.